drugset / Trial / NCT03591913

Preoperative and Postoperative Sublingual Misoprostol for Prevention of Postpartum Blood Loss in Cesarean Section

NCT03591913

Phase 4 Completed 500 enrolled Assiut University
RandomizedParallel-groupSingle-blindPrevention

Summary

Cesarean section is one of the most common major surgical operations among women. In 2015, the incidence of cesarean section in Woman Health Hospital in Assiut University accounts for 51.3 % of all deliveries

Timeline

Start
2018-02-01
Primary completion
2018-08-01
Completion
2018-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified Other

Indications

No indication recorded.